Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

SMC Update - January 2010

The Scottish Medicines Consortium (SMC) has issued its monthly advice on new medicines.

Eslicarbazepine acetate (Zebinix®) has been rejected for use as an adjunctive therapy in adults with partial-onset seizures with or without secondary generalisation. The review notes that efficacy has been demonstrated in three 12-week placebo controlled trials but that no active comparator studies have been completed. The economic analysis in the submission was not sufficiently robust to gain acceptance.

Action: Clinicians should be aware of the recommendations of the SMC. Routine use of rejected and restricted medicines should be avoided.

Share 'SMC Update - January 2010' on Email Share 'SMC Update - January 2010' on Delicious Share 'SMC Update - January 2010' on Digg Share 'SMC Update - January 2010' on Facebook Share 'SMC Update - January 2010' on reddit Share 'SMC Update - January 2010' on StumbleUpon Share 'SMC Update - January 2010' on Twitter

atomic-wealth

No Comments to “SMC Update - January 2010”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.

atomic-wealth
fond-illness
summer